CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCE
Go back to CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCE| CVS Caremark Corp. (NYSE: CVS) | Delayed: 101.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $101.30 | 52 Week High | $106.67 | |||
| Open | $101.30 | 52 Week Low | $69.30 | |||
| Day High | $101.30 | P/E | 27.01 | |||
| Day Low | $101.30 | EPS | $3.75 | |||
| Volume | 5,351 | |||||

